Navigation Links
Photos: Niavin Corporation Offers Pain Sufferers a New Way to Address Pain
Date:1/30/2008

Trigger Points Provide Pain Relief Alternative To Prescription and

Over-The-Counter Medications

LOS ANGELES, Jan. 30 /PRNewswire/ -- One in ten Americans report suffering regularly from various physical aches, pains and debilitating arthritis. Most often, pain sufferers reach for relief in a pill without considering the source of the pain, and how to treat it safely, effectively and more holistically. In an effort to educate consumers about pain relieving alternatives, a new company, Niavin Corporation, is launching a series of national television advertisements featuring Niavin Trigger Point Relief and offering a new way to understand and treat pain at its source: The Trigger Point.

To view the Multimedia News Release, go to:

http://www.prnewswire.com/mnr/niavin/31633/

Company founder, Dr. Francois Martin, explains the benefits of Niavin Trigger Point Relief over current treatments: "Niavin is applied directly at the trigger points -- relaxing and deactivating the points where pain radiates throughout the body. Most topical pain relievers are applied incorrectly and exclusively to where the pain is felt. This limited application method offers short-term pain relief, often only masking pain with a counter-irritant, heating or cooling effect -- essentially a distraction from the pain, without addressing the root cause."

In addition, Dr. Martin explains that, "Unlike pills, Niavin is absorbed directly into the bloodstream through the skin, lymphatic system and targeted cells. Bypassing the stomach, liver and digestive system is advantageous towards eliminating the risk of common side effects such as irritated stomach lining, upset stomach, bleeding, allergies, addiction and dependence."

Niavin is a clinically proven, topical pain medication derived from a proprietary blend of absorption enhancing essential oils and aromath
'/>"/>

SOURCE Niavin Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Photos: Drink Wine and Live Longer - 1907 Madiran and Plaimont Wines of Southwest France Sponsor the Launch of The Red Wine Diet
2. Photos: Americas Chronically Ill Children Have New Hope with Hot Gift
3. Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning
4. STERIS Corporation Announces Fiscal 2008 Third Quarter Results
5. Digirad Corporation to Release Fourth Quarter, Year-End Financial Results on February 7, 2008
6. XLHealth Corporation Announces Executive Changes
7. CEL-SCI Corporation Releases Letter to Shareholders
8. Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock(R) Set Saver
9. United American Healthcare Corporation To Host Fiscal 2008 Second Quarter Results Conference Call Feb. 7
10. MedCath Corporation to Hold Conference Call on First Quarter Results
11. STERIS Corporation Declares Regular Quarterly Dividend

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...FraternalOrderofPolicedistributedturkeys,cannedfoo..., PORTJERVIS,N.Y.,Nov.24/PRNewswire-USNewswire/--...shipwiththeNewYorkStateFraternalOrderofPolice,host...k,sChildDevelopmentCenter,ProjectDiscoveryinPortJe...eivefreeturkeys,ham,chickenandothertrimmingstoprov...
(Date:11/24/2009)...-Mostpeoplelookforwardtokickingofftheholidayseason...ndfamily.TheMacombCountyHealthDepartmentremindsyou...lingandbeinginlargegroupsareeasywaystospreadfluger...VACCINATION ,, Thefirstandmostimportantstepisf...insttheH1N1strainoftheflu.TheMacombCountyHealthDep...
(Date:11/24/2009)...theholidayseasonoftenbringsfamiliesandfriendstoget...hosegrievingthedeathofalovedone.Followingadeath,ev...seasoncanbringadditionalchallengestothosewhoaregri...vingChildren,AdolescentsandTheirFamilies,isavailab...yofprintandonlineresourcesavailabletohelpchildreng...
(Date:11/24/2009)...ionLaborLifeInsuranceCompany("UnionLaborLife")anno...ion,slargestvisionbenefitsandservicescompany,topro...rustfunds,unionemployersandtheirmembers. ,, VSP...ngcomprehensiveeyeexams,broadselectionsofopticalfr...eis,"statedBruceSmith,NationalSales,VSP."Comprehen...
(Date:11/24/2009)...too loud, or contain dangerous chemicals , ...oliday shopping season begins, parents need to kno... stores across the United States. , That,s the ... report, released Tuesday by the U.S. Public Inter... on toys that pose a choking hazard, are excessive...
Breaking Medicine News(10 mins):Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3
...study, published in the June 6 issue of JAMA, has ...itary diffuse gastric cancer. It states that thes... events and common ancestry. The study has been re...ormation in the article, gastric cancer is the sec...
...SHINGTON, DC A new study published in the journal ...ssociation (APA), states that young adults with a ...promised lung function. The condition persisted ev...ur metropolitan areas (sampled from the Coronary A...
...ICAGO, A five-year follow-up of National Surgical...-31, presented at the annual meeting of the Americ... states that the risk of congestive heart failure ...rch team developed a prediction model based on the...
...ICAGO Findings presented today at the American So...alanis, M.D., a Mayo Clinic oncologist, reveals th...ws activity in patients with recurrent glioblastom... lead investigator of the study. Glioblast...
...itical care, emergency service and intensive care ... Rs.300 million boost from its new owner Fortis He....300 million) in Escorts within two years," Fortis...ot getting the desired focus for the last 20 month...
...cistm does upset those at the receiving end, even ...al slights and ambiguous remarks that are hard to ...overt discrimination, according to a study of 180 ...mptoms of depression and anxiety," said lead autho...
Other Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Unhealthy Lungs Linked to Hostility? 2Health News:Long-term Use of Herceptin Does Not Increase Heart Failure in Patients 2Health News:Recurrent Gliomas: Vorinostat Shows Anti-cancer Activity 2Health News:Fortis to Inject Rs.300 Mn into Escorts Hospital 2Health News:Koreans in Canada Feel Put Down by Subtle Racism 2
(Date:11/24/2009)...ANDIEGO,Nov.24/PRNewswire-FirstCall/--OptimerPharm...atthe21stAnnualPiperJaffrayHealthCareConferenceatT...p.m.EasternTime. ,, (Logo: http://www.newscom.c...audiowebcastofthispresentationwillbeaccessibleonth...pharma.com .Replaysofthispresentationwillbeavaila...
(Date:11/24/2009)...EWYORK,Nov.24/PRNewswire-FirstCall/--KeryxBiopharm...nBentsur,theCompany,sChiefExecutiveOfficer,issched...ConferencebeingheldinNewYorkCity. ,, Mr.Bentsur...r2ndat10:30AMETandwillbeaccessiblefromtheInvestorI...tors.keryx.com .Anarchivedversionofthewebcastwillb...
(Date:11/24/2009)...YNBROOK,N.Y.,Nov.24/PRNewswire-FirstCall/--BioSpec...uticalcompanydevelopingfirstinclasscollagenase-bas...t,TomWegman,willpresentattheupcomingPiperJaffray21...09,at3:30pmETatTheNewYorkPalaceHotelinNewYork,NY. ...der"CalendarofEvents"intheInvestorRelationssection...
Breaking Medicine Technology:Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Minorities have poorer results higher rates of inappropriate surgery to prevent stroke 55308 1Minorities have poorer results higher rates of inappropriate surgery to prevent stroke 55308 2Ellison Medical Foundation awards more than 241 million to mid career scientists 55303 1Ellison Medical Foundation awards more than 241 million to mid career scientists 55303 2New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 1New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 2New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 3New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 4New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 5
...sdaq: IOMI ) today announced that Stanley C. Erck...cer, will present at the Acumen BioFin,Rodman & Re... City on,Monday, Nov. 5. Mr. Erck,s presentation w... I Room of the New York Palace Hotel. Mr. Erck,s ...tch-based,needle-free vaccines and immunostimulant...
...alled POLI 1 -, BOSTON, Nov. 2 R1626, one of Roc...is C virus (HCV) infection, has,shown promising an...GASYS(R) (peginterferon alfa-2a) and COPEGUS(TM) (...t the American Association for the Study of the,Li... Nov. 2-6. After four,weeks of treatment with this...
Other Medicine Technology:Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5 2Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 2Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 3Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 4Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 5Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 6Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 7
Kremer Angled Fixation Forceps
...nsworth 100 Hue Test including MS-Excel scoring te... Farnsworth 100 Hue Test comes boxed in clear acry... the potential for test disruption by holding the... test from Richmond Products includes 93 color dis...
Farnsworth's D15 Test
... 4th edition pseudoisochromatic test from Richmond...the six screener plates and the 14 diagnostic seri...has its own tab for easy and clean page selection....nglish and a laminated copy of the score sheet. Th...
Medicine Products: